Aug 14, 2026 01:50AM
Aug 13, 2026 04:01PM
Aug 6, 2026 09:05AM
May 26, 2026 08:01AM
May 26, 2026 08:00AM
May 18, 2026 08:01AM
May 18, 2026 08:00AM Daré Bioscience Initiates Phase 2 Study of DARE-HPV, a Novel Pharmacologic Treatment for Persistent High-Risk HPV Infection with No FDA-Approved Therapies
May 14, 2026 04:08PM
May 14, 2026 04:01PM
May 12, 2026 08:01AM
May 12, 2026 08:00AM
May 7, 2026 08:00AM
Mar 26, 2026 04:01PM
Mar 23, 2026 08:00AM On National Viagra Day, Women Finally Claim Their Turn:
Mar 20, 2026 08:00AM
Mar 16, 2026 08:02AM
Mar 16, 2026 08:00AM
Mar 12, 2026 08:00AM
Feb 23, 2026 08:01AM
Feb 23, 2026 08:00AM
Feb 11, 2026 08:00AM Telehealth Now Available for DARE to PLAY™ Sildenafil Cream: First Evidence-Based Topical Arousal Cream for Women
Dec 10, 2025 08:01AM
Dec 10, 2025 08:00AM
Dec 1, 2025 08:03AM
Dec 1, 2025 08:00AM
Nov 24, 2025 08:01AM
Nov 24, 2025 08:00AM
Nov 13, 2025 05:26PM Dare Bioscience (DARE) Misses Q3 EPS by 28c
Nov 13, 2025 04:01PM
Nov 11, 2025 08:00AM
Nov 6, 2025 08:00AM
Nov 3, 2025 08:00AM
Oct 6, 2025 08:03AM
Oct 6, 2025 08:00AM
Sep 24, 2025 08:00AM Daré Bioscience to Receive up to $499,000 to Support Preeclampsia Research
Aug 14, 2025 04:48PM
Aug 14, 2025 04:01PM
Aug 7, 2025 08:00AM
Jul 29, 2025 08:00AM
Jul 21, 2025 01:47PM
Jul 21, 2025 08:00AM
Jul 14, 2025 08:03AM Daré Bioscience reports interim Phase 3 results for hormone-free contraceptive
Jul 14, 2025 08:00AM
Jul 11, 2025 08:00AM
Jul 11, 2025 08:00AM
Jun 4, 2025 08:01AM
Jun 4, 2025 08:00AM
May 13, 2025 07:04PM
May 13, 2025 04:01PM Daré Bioscience Reports First Quarter 2025 Financial Results and Provides Company Update
May 6, 2025 08:00AM

1,219,412 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All